- Home
- JAGX vs SVRE Comparison
JAGX vs SVRE Comparison
Compare JAGX & SVRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAGX
- SVRE
- Stock Information
- Founded
- JAGX 2013
- SVRE 2014
- Country
- JAGX United States
- SVRE Israel
- Employees
- JAGX N/A
- SVRE N/A
- Industry
- JAGX Biotechnology: Pharmaceutical Preparations
- SVRE
- Sector
- JAGX Health Care
- SVRE
- Exchange
- JAGX Nasdaq
- SVRE Nasdaq
- Market Cap
- JAGX 3.1M
- SVRE 2.9M
- IPO Year
- JAGX N/A
- SVRE 2022
- Fundamental
- Price
- JAGX $4.67
- SVRE $3.62
- Analyst Decision
- JAGX
- SVRE
- Analyst Count
- JAGX 0
- SVRE 0
- Target Price
- JAGX N/A
- SVRE N/A
- AVG Volume (30 Days)
- JAGX 39.3K
- SVRE 14.0K
- Earning Date
- JAGX 03-31-2025
- SVRE 03-21-2025
- Dividend Yield
- JAGX N/A
- SVRE N/A
- EPS Growth
- JAGX N/A
- SVRE N/A
- EPS
- JAGX N/A
- SVRE N/A
- Revenue
- JAGX $11,689,000.00
- SVRE $462,071.00
- Revenue This Year
- JAGX $18.18
- SVRE $597.62
- Revenue Next Year
- JAGX $40.06
- SVRE N/A
- P/E Ratio
- JAGX N/A
- SVRE N/A
- Revenue Growth
- JAGX 19.75
- SVRE N/A
- 52 Week Low
- JAGX $4.40
- SVRE $0.30
- 52 Week High
- JAGX $540.00
- SVRE $21.24
- Technical
- Relative Strength Index (RSI)
- JAGX 20.41
- SVRE 49.42
- Support Level
- JAGX $4.41
- SVRE $2.96
- Resistance Level
- JAGX $4.97
- SVRE $5.45
- Average True Range (ATR)
- JAGX 0.88
- SVRE 0.36
- MACD
- JAGX 0.09
- SVRE -0.26
- Stochastic Oscillator
- JAGX 3.35
- SVRE 26.53
About JAGX Jaguar Health Inc.
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.
About SVRE SaverOne 2014 Ltd.
Saverone 2014 Ltd provides driver protection solutions. The company develops and deploys ADAS technologies for transportation safety and driver assistance. The company's product restricts the driver from surfing, communicating, and receiving alerts while driving. The Company has developed a system that provides a solution to the problem of distracted driving caused by cell phone use, which endangers the driver, passengers, other drivers on the road, and pedestrians.